Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > 4050 still on hold because they say we need to analyse pk da
View:
Post by edrose on Jan 17, 2022 12:22pm

4050 still on hold because they say we need to analyse pk da

Data before we proceed to next step it doesn't take that much time to analyse data on FEW patients 


it will interesting when they question scientists under oath 

There's a reason why they are delaying what do people think
Comment by Dibah420 on Jan 17, 2022 2:04pm
Delay is  standard practice in litigation.  Eventually the judge wakes up and puts his foot down.
Comment by stockbuphoon on Jan 18, 2022 11:46am
Doing nothing is a delay tactic that favours Thomvest as majority shareholder and SALP affiliate who owns the debt. This scenario is a benefit also in the lawsuit suggesting that there is no value left in this company so they were fooled by previous management. too. They have stopped any communication and even stopped quarterly conference calls. Alstrom, IPF and Metabolic Syndrome results ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities